Orchid Chemicals completes business transfer to Hospira
March 31st, 2010 - 12:03 am ICT by IANSChennai, March 30 (IANS) City-based Orchid Chemicals & Pharmaceuticals Ltd Tuesday announced the completion of sale and transfer of its generic injectable finished dosage business to Hospira Healthcare India Pvt Ltd, a wholly owned subsidiary of Hospira Inc, US.
Orchid Chemicals and Hospira had signed a business transfer agreement last December to sell its injectibles business, the manufacturing complex, research and development facility at Irungattukottai near here along with employees for $400 million.
Hospira, which has a 50:50 joint venture with the Ahmedabad-based Zydus Cadilla for manufacture of oncological drugs, looked at Orchid Chemicals’ betalactam plant near here as an apt fit as it did not have a presence in that segment.
What further attracted the American company to Orchid Chemicals’ plant is the regulatory approvals it had, including one from USFDA (US Food and Drug Administration).
According to Orchid’s managing director K. Raghavendra Rao, the completion of the deal will enable the company to de-lever its balance sheet and achieve financial flexibiility.
“In addition, through the strategic supply arrangement with Hospira, Orchid would be ensuring long term contractual API (active pharmaceutical ingredients) revenue streams,” he said.
Orchid’s deputy managing director C.B.Rao will be heading Hospira India as its managing director.
- Orchid Chemicals completes business transfer to Hospira - Mar 31, 2010
- Orchid Chemicals sells 'pearl' to Hospira - Dec 16, 2009
- Orchid Pharma to invest Rs.200 crore in niche segment - Nov 04, 2010
- US health regulator approves Chennai drug plant - Jun 22, 2011
- Orchid Chemicals' plant shut on pollution concerns - Jul 11, 2011
- Orchid Chemicals to invest Rs.200 crore this fiscal - Jul 29, 2011
- Orchid Chemicals to pay off debt by selling business - Dec 16, 2009
- Hospira eyeing Indian partners to make medical devices - Dec 17, 2009
- Orchid Chemicals signs out-licensing deal with Alvogen - May 05, 2010
- Orchid Chemical to acquire US marketing company - Jun 10, 2010
- Decks cleared for Orchid to market anti-infectives in US - Sep 25, 2009
- Orchid Chemicals declares 30 percent dividend - May 18, 2011
- Core Gestra bags pharma excellence award - May 26, 2011
- Zydus Cadila buys out Biochem - Dec 21, 2011
- Hotel prices fell by 17 percent: Report (Business Capsule) - Sep 16, 2009
Tags: active pharmaceutical ingredients, balance sheet, business transfer, food and drug, food and drug administration, hospira, hospira inc, india pvt ltd, joint venture, managing director, orchid chemicals, pharmaceuticals, raghavendra rao, regulatory approvals, research and development, revenue streams, segment, supply arrangement, usfda, zydus cadilla